-
NMPA Announcement on Issuing the Standard for the Evaluation of Efficacy Claims of Cosmetics
2021-04-09
The NMPA has organized to formulate the Standard for the Evaluation of Efficacy Claims of Cosmetics, which was issued on April 8 and shall take effect as of May 1, 2021.
-
NMPA Announcement on Issuing the Classification Rules and Classification Catalogue of Cosmetics
2021-04-09
The NMPA has formulated the Classification Rules and Classification Catalogue of Cosmetics, which was issued on April 8 and shall take effect as of May 1, 2021.
-
NMPA Announcement on Issues about Implementing the Rules for Registration and Notification Dossiers of Cosmetics
2021-03-05
In order to implement the Regulations for the Supervision and Administration of Cosmetics and the Provisions for Registration and Notification of Cosmetics and further standardize the administration on registration and notification of cosmetics, the issues about implementing the Rules for the Registration and Notification Dossiers of Cosmetics is hereby announced as follows.
-
NMPA Announcement on Issuing the Rules for Registration and Notification Dossiers of Cosmetics
2021-03-04
The NMPA has developed the Rules for Registration and Notification Dossiers of Cosmetics, which is hereby issued and shall take effect as of May 1, 2021.
-
NMPA Announcement on Issuing the Rules for Registration and Notification Dossiers of New Cosmetic Ingredients
2021-03-04
The NMPA has developed the Rules for Registration and Notification Dossiers of New Cosmetic Ingredients, which is hereby issued and shall take effect as of May 1, 2021.
-
NMPA Announcement on Revising the Package Insert of Misoprostol Tablets for Obstetrical and Gynecological Application
2021-02-26
To further protect public medication safety, the NMPA decided to revise the package insert of Misoprostol Tablets for obstetrical and gynecological application. Relevant issues are hereby announced as follows.